Hockey Fans in Training (Hockey FIT): Improving Men's Health Through the Power of Sport

June 2, 2023 updated by: Robert Petrella, Western University, Canada

Hockey Fans in Training (Hockey FIT): A Pragmatic Cluster Randomized Controlled Trial to Improve Men's Health Through the Power of Sport

Hockey Fans in Training (Hockey FIT) is a 12-month (3-month active phase and 9-month minimally-supported phase) weight loss and healthy lifestyle program for middle-aged, male hockey fans with overweight or obesity, delivered by trained coaches in collaboration with major junior or professional hockey teams and implementation partners (e.g., YMCAs, local fitness facilities, and universities) in Canada and the United States.

In the proposed study, a minimum of 32 sites (affiliated with hockey teams and local implementation partners) will be randomly assigned to either immediate delivery (Hockey FIT program) or delayed delivery (wait-list control). At each site, male hockey fans at risk for chronic diseases will be recruited to take part in the study (note: the goal is to recruit approximately 40 men/site). Sites assigned to the delayed delivery group will offer the Hockey FIT program to their enrolled participants after 12 months.

Through the Hockey FIT program, the investigators aim to promote weight loss, increase physical activity levels, and improve other health measures through a cost-effective solution that is acceptable and appealing to men who have overweight or obesity.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The overall goal of this study is to reduce preventable chronic diseases in men by improving health behaviours and health indicators. To achieve this goal, following a successful pilot study providing strong evidence to proceed with a definitive trial, the investigators are conducting a pragmatic, cluster randomized controlled trial (RCT) of the Hockey FIT program.

The primary specific aim is to conduct an outcome evaluation to evaluate the effectiveness of Hockey FIT in middle-aged men who have overweight or obesity. Specifically, the investigators will: examine whether Hockey FIT (vs. wait-list control) leads to: greater weight loss at 12 months (primary outcome), as well as improved health behaviours (physical activity; sedentary time; eating habits) and health indicators (physiological measures; health & psychosocial measures) at 3 and 12 months.

Following the pilot study, the investigators will use the affiliation of being a fan of hockey as a powerful draw to engage men. Sites will be selected based on availability of both a major junior (or professional) hockey team and an implementation partner (e.g., YMCA branch, fitness facility, University) located in the city. A minimum of 32 sites in Canada and the United States will be randomized to the intervention (Hockey FIT program: immediately delivery) or comparator (wait-list control: delayed delivery); at each site, men will be recruited to participate (with the goal of recruiting approximately 40 men/site). Intervention sites will begin Hockey FIT immediately while comparator sites will offer Hockey FIT after a 12-month delay. The measurement sessions involving both groups will take place at 0 (baseline), 3 and 12 months.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
997

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Alberta
      • Brooks, Alberta, Canada
        • City of Brooks
      • Calgary, Alberta, Canada
        • Mount Royal University
      • Lethbridge, Alberta, Canada, T1K 3M4
        • University of Lethbridge
      • Medicine Hat, Alberta, Canada, T1A 3A9
        • Downtown Medicine Hat YMCA
      • Red Deer, Alberta, Canada, T4P 3E9
        • Northside Community Centre YMCA of Northern Alberta
    • British Columbia
      • Chilliwack, British Columbia, Canada, V2P 8G1
        • Club XO Fitness
      • Kamloops, British Columbia, Canada, V2C 2L7
        • YMCA Kamloops
      • Kelowna, British Columbia, Canada, V1Y 6V8
        • YMCA Okanagan
      • Langford, British Columbia, Canada, V9B 0S2
        • YMCA-YWCA Westhills
      • Langley, British Columbia, Canada, V2Y 3J4
        • Langley Events Centre
      • Penticton, British Columbia, Canada, V2A 7K9
        • Penticton Community Centre
      • Prince George, British Columbia, Canada, V2L 4V7
        • YMCA of Northern BC
      • Salmon Arm, British Columbia, Canada, V1E 2S4
        • Shaw Centre
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 0V2
        • Avenir Centre
      • Saint John, New Brunswick, Canada, E2J 1A2
        • Afterburn Performance
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3J 1L2
        • YMCA of Halifax and Dartmouth
    • Ontario
      • Barrie, Ontario, Canada, L4N 1M7
        • Barrie YMCA
      • Belleville, Ontario, Canada, K8N 2G1
        • YMCA of Central Eastern Ontario - Belleville Branch
      • Hamilton, Ontario, Canada, L8P 2Z1
        • Les Chater Family YMCA
      • Kingston, Ontario, Canada, K7L 4T9
        • YMCA of Kingston
      • Kitchener, Ontario, Canada, N2G 3C5
        • A.R. Kaufman Family YMCA
      • London, Ontario, Canada, N6K 3X4
        • Bostwick YMCA
      • Mississauga, Ontario, Canada, L5B 3R2
        • Mississauga Burnhamthorpe Rd. YMCA Centre
      • North Bay, Ontario, Canada, P1B 6G2
        • YMCA of North Bay
      • Oshawa, Ontario, Canada, L1G 8C1
        • Oshawa Mary Street YMCA Centre
      • Owen Sound, Ontario, Canada, N4K 0C6
        • YMCA of Owen Sound Grey Bruce
      • Peterborough, Ontario, Canada, K9J 3H8
        • Balsillie Family YMCA
      • Sarnia, Ontario, Canada, N7S 6G5
        • YMCA Jerry McCaw Family Centre
      • Sault Ste Marie, Ontario, Canada, P6B 1Y3
        • YMCA of Sault Ste Marie
      • St. Catharines, Ontario, Canada, L2N 7P9
        • Walker Family YMCA
      • Sudbury, Ontario, Canada, P3E 3M7
        • YMCA Sudbury
      • Windsor, Ontario, Canada, N7G 4H5
        • YMCA at Central Park Athletics
    • Prince Edward Island
      • Charlottetown, Prince Edward Island, Canada, C1A 4P3
        • University of Prince Edward Island
    • Saskatchewan
      • Prince Albert, Saskatchewan, Canada, S6W 1A1
        • CBI Health Centre
      • Regina, Saskatchewan, Canada, S4S 0A2
        • University of Regina
      • Saskatoon, Saskatchewan, Canada, S7K 0C7
        • YMCA of Saskatoon
      • Swift Current, Saskatchewan, Canada, S9H 3W1
        • Lt. Colonel Clifton Centre
  • United States
    • Michigan
      • Flint, Michigan, United States, 48503
        • Dort Federal Credit Union Event Center
      • Saginaw, Michigan, United States, 48710
        • Saginaw Valley State University
    • Oregon
      • Portland, Oregon, United States, 97227
        • Veterans Memorial Coliseum

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

35 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Male;
  2. Between 35 and 65 years of age;
  3. Objectively-measured body-mass index of at least 27 kg/m2
  4. Deemed safe to participate in physical activity [i.e., clear the 2018 Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) or receive written clearance from a health care provider].

Exclusion Criteria:

1) Advised by a health care provider to not participate in the program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Hockey FIT Program (Immediate Delivery)
Hockey FIT Program: A gender-sensitized, weight loss and healthy lifestyle program that engages men using the power of being a sports fan.
Behavioral: Hockey FIT Program (Immediate Delivery)

Hockey FIT is comprised of a 3-Month Active Phase and a 9-Month Minimally-Supported Phase.

Active Phase: 12 weekly, 90-minute group-based sessions consisting of classroom-based education and exercise. Outside of sessions, participants follow their individualized lifestyle prescriptions for healthy eating, physical activity (steps), and exercise. Participants are encouraged to regularly use health technology support tools customized to Hockey FIT. Minimally-supported phase: Participants are encouraged to continue with their healthy lifestyle behaviour changes and to regularly use the health technology support tools.
No Intervention: Wait-List Control (Delayed Delivery)
No intervention for 12 months. After 12 months, Hockey FIT program is offered.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Weight loss (absolute)
Time Frame: 12 months
Measured using a digital weight scale (in kg)
12 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Weight loss (absolute)
Time Frame: 3 months
Measured using a digital weight scale (in kg)
3 months
Weight loss (percent change)
Time Frame: 3 months & 12 months
Measured using a digital weight scale (% change from baseline)
3 months & 12 months
Predicted maximal oxygen uptake (VO2max)
Time Frame: 3 months & 12 months
Calculated from sub-maximal fitness test (in mL/kg/min)
3 months & 12 months
Systolic blood pressure
Time Frame: 3 months & 12 months
Measured using an automated blood pressure monitor (in mm Hg)
3 months & 12 months
Diastolic blood pressure
Time Frame: 3 months & 12 months
Measured using an automated blood pressure monitor (in mm Hg)
3 months & 12 months
Body mass index
Time Frame: 3 months & 12 months
Calculated from weight (digital weight scale) and height (portable stadiometer) (in kg/m2)
3 months & 12 months
Waist circumference
Time Frame: 3 months & 12 months
Measured using tape measure (in cm)
3 months & 12 months
Glycated hemoglobin (A1c)
Time Frame: 3 months & 12 months
Measured using a point-of-care analyzer (%)
3 months & 12 months
Daily steps
Time Frame: 3 months & 12 months
Measured using a waist-worn accelerometer-based step counter over 7 days (average steps/day)
3 months & 12 months
Total physical activity MET-minutes/week
Time Frame: 3 months & 12 months
Measured using the International Physical Activity Questionnaire (IPAQ) - Short Form (sum of Walking + Moderate + Vigorous MET-minutes/week)
3 months & 12 months
Vigorous physical activity MET-minutes/week
Time Frame: 3 months & 12 months
Measured using the International Physical Activity Questionnaire (IPAQ) - Short Form (calculated as 8.0 * vigorous-intensity activity minutes * vigorous-intensity days)
3 months & 12 months
Moderate physical activity MET-minutes/week
Time Frame: 3 months & 12 months
Measured using the International Physical Activity Questionnaire (IPAQ) - Short Form (calculated as 4.0 * moderate-intensity activity minutes * moderate-intensity days)
3 months & 12 months
Walking MET-minutes/week
Time Frame: 3 months & 12 months
Measured using the International Physical Activity Questionnaire (IPAQ) - Short Version (calculated as 3.3 * walking minutes * walking days)
3 months & 12 months
Total time spent sitting (on a week day)
Time Frame: 3 months & 12 months
Measured using the Marshall Questionnaire (in minutes)
3 months & 12 months
Healthful eating score
Time Frame: 3 months & 12 months
Measured using the Starting the Conversation (STC) Questionnaire (summary score of 8 items; score range, 0-16; lower score indicates more healthful eating)
3 months & 12 months
Fruit and vegetable intake
Time Frame: 3 months & 12 months
Measured using the Canadian Community Health Survey
3 months & 12 months
Sweetened sugary beverages intake
Time Frame: 3 months & 12 months
Measured using the Behavioral Risk Factor Surveillance System Questionnaire
3 months & 12 months
Total alcohol intake (weekly)
Time Frame: 3 months & 12 months
Measured using a 7-day recall diary
3 months & 12 months
Smoking status
Time Frame: 3 months & 12 months
Measured using questions adapted from the Canadian Community Health Survey
3 months & 12 months
Overall self-rated health status
Time Frame: 3 months & 12 months
Measured using the EQ-5D 5 level version, specifically using the EQ visual analogue scale (EQ-VAS; range, 0-100; higher score indicates better self-rated health where 100 = best imaginable health state)
3 months & 12 months
Well-being score
Time Frame: 3 months & 12 months
Measured using the World Health Organization (Five) Well-Being Index (raw score is calculated from totalling 5 items and is converted to a percentage score when multiplied by 4; percentage score range, 0-100; higher score indicates better better quality of life where 100 represents best possible quality of life)
3 months & 12 months
Social connectedness score
Time Frame: 3 months & 12 months
Measured using the Duke Social Support Index (total score range, 11-33; higher values indicate higher levels of support)
3 months & 12 months
Sleep quality global score
Time Frame: 3 months & 12 months
Measured using the Pittsburgh Sleep Quality Index (calculated by totalling the sum of 7 component scores; score range, 0-21; higher scores indicate worse sleep quality)
3 months & 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Western University, Canada

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Canadian Institutes of Health Research (CIHR)
Public Health Agency of Canada (PHAC)

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Robert Petrella, MD, PhD, Western University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 13, 2018

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 28, 2022

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 3, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 25, 2018

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 14, 2018

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 17, 2018

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 7, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 2, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 111881

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Hockey FIT Program (Immediate Delivery)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings